Prophylaxis With High-Dose Methotrexate Significantly Reduces CNS Dissemination in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) and High-Risk CNS-IPI Score
Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_60
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Wiley